found that intratumoral IL-17 expression was an independent factor affecting the five-year overall survival probability in patients with gastric adenocarcinoma (HR: 0.52; 95% CI: 0.33-0.82; P=0.005) (40). The gene discussed is IL17A; the disease is gastric adenocarcinoma.